GenF20 Plus Review: What the Published Study Actually Found
GenF20 Plus is one of the best-known “natural HGH releasers” on the market, and its marketing leans on a single number: a 28% rise in IGF-1 over 12 weeks. That number does appear in a published paper. But we read the paper from start to finish, and it tells a much less flattering story than the headline. The trial’s main result was not statistically significant, the 28% figure comes from a subgroup analysis the researchers ran after the results were in, and the authors themselves concluded the product “may not have delivered the projected efficacy results.” This review explains what that means in plain language, and what is still worth knowing about the product.
What the Published Study Actually Found
Here is the result for the primary outcome. IGF-1 rose by an average of 13.46 ng/mL in the GenF20 Plus group and 6.35 ng/mL in the placebo group. That difference was not statistically significant, and the authors said so directly, writing that the increase was “neither clinically nor statistically significant.” In other words, on the question the trial was designed to answer, the answer was no measurable difference from placebo.
The researchers then split participants by age after the results were in, which the paper labels a “post hoc” analysis. Among adults 40 and older, the raw difference still was not significant (an average rise of 14.59 ng/mL versus 3.17 ng/mL for placebo). It crossed the significance line only after a statistical adjustment for baseline IGF-1 levels, which the authors applied because those baselines differed between the subgroups. After that adjustment, the change came out to 28.57% in the GenF20 Plus group versus −0.55% in placebo. That adjusted, after-the-fact, subgroup figure is the “28%” in the marketing.
That doesn’t make the finding meaningless. It is a reasonable hypothesis that older adults, who have lower IGF-1 to begin with, have more room to respond. But it is a hypothesis the trial generated, not one the trial was built to test, and the authors themselves called for longer and larger studies to follow up. In our research we did not come across such a follow-up trial.
Nothing Else Separated From Placebo
Waist circumference, BMI, body fat percentage, and lean muscle mass showed no significant difference between the groups. Memory, libido, energy, and sleep scores improved over the 12 weeks, but they improved in the placebo group too, and the difference between groups was not statistically significant. Overall satisfaction was rated positively by 67.7% of the GenF20 Plus group and 60% of the placebo group, also not a significant difference.
Two more details are worth knowing. First, the trial had no sample-size calculation; the authors describe it as the first exploratory study on the product and chose the numbers arbitrarily. Second, on funding: the study was run by a contract research organization, Vedic Lifesciences, which states it is independent and unrelated to the sponsor, and was financed by DM Contact Management. The paper does not explain how the sponsor is connected to the brand, and the full study report is hosted on a GenF20-branded website. We treat this as a sponsored trial, conducted by an independent research organization and published in a peer-reviewed open-access journal. That is a real point in the product’s favor compared with the many competitors that have no published trial at all, but it is not the same as independent replication.
Marketing vs. the Paper
The gap between what the paper reports and how it is summarized on promotional pages is the single most important thing to understand about this product. Here are the most common claims side by side with what we found in the source.
| What you’ll see promoted | What the paper shows |
|---|---|
| IGF-1 increased 28% in 12 weeks | Only as an adjusted, post hoc figure in the 40+ subgroup. The overall difference versus placebo was not significant. |
| “Clinically proven to reverse the signs of aging” | No significant difference from placebo in body fat, lean mass, memory, libido, energy, or sleep. |
| A study of 61 participants | 70 were randomized. 61 completed and were analyzed; seven withdrew because they were unwilling to undergo laboratory tests, and two were lost to follow-up. |
| Results apply to the tablets | Participants took the tablets and an oral liquid together. The tablets alone were not tested. |
The quoted claim in the second row comes from the manufacturer’s own product page. Growth-hormone marketing tends to treat “clinically studied” and “clinically proven” as interchangeable. They aren’t, and this trial is a good example of why.
The Rudman Connection
HGH supplement marketing, including material around GenF20 Plus, often leans on the work of Dr. Daniel Rudman, and the trial paper itself cites him in its discussion section. Rudman’s 1990 study in the New England Journal of Medicine followed 21 healthy men aged 61 to 81 with low IGF-1. Twelve of them received biosynthetic human growth hormone, injected under the skin three times a week for six months, and showed changes in lean body mass and fat mass.
It is a genuine, important study, but it measured body-composition changes in a small group; it did not show that anyone’s aging was reversed. And it tested prescription-grade injected hormone in older men, not an oral blend of amino acids and animal-derived powders. Nothing in that study says an oral supplement can produce comparable effects, and the GenF20 Plus trial’s own results, described above, don’t show that it did. Borrowing the credibility of injectable-HGH research for a capsule is a category error we see across this whole product type.
How the Formula Is Meant to Work
The trial’s authors describe the intended mechanism this way: the ingredients are meant to stimulate the anterior pituitary gland to release more growth hormone, which travels to the liver and prompts it to produce IGF-1. The logic is that certain amino acids are known to influence growth hormone release, and that combining several of them with other compounds could nudge the system upward in people whose output has declined with age.
The mechanism is biologically plausible in general terms; the open question, which the trial addresses only partially, is whether the specific amounts in an oral supplement are enough to produce a real, measurable, sustained effect in everyday use.
Every Ingredient, Examined
The trial paper lists the full formula that was tested. The tablets contained L-glutamine, L-arginine, L-glycine, L-tyrosine, Tribulus terrestris extract, L-lysine, astragalus root, colostrum powder, deer velvet antler powder, GABA, L-isoleucine, anterior pituitary powder, phosphatidylcholine, L-valine, L-ornithine, and glucose-tolerance factor chromium. The oral liquid contained alpha-GPC, GABA, Mucuna pruriens, moomiyo extract, ornithine alpha-ketoglutarate, and several of the same amino acids. Here is what we could verify about the ones that matter most.
Intravenous arginine is a standard endocrine test for provoking growth hormone release, and one study the trial cites found that arginine plus ornithine raised GH and IGF-1 in strength-trained athletes after heavy resistance exercise. That is a different situation from a resting middle-aged adult taking capsules. Oral arginine also has a well-documented absorption limitation, since much of an oral dose is broken down before reaching the bloodstream, so the amount that matters is the amount that survives digestion, not the number on the label.
The trial’s authors point to a study finding that an oral mixture of glycine, glutamine, and niacin raised serum HGH by 70% relative to placebo. Worth noting: that mixture included niacin, which is not on the GenF20 Plus ingredient list in the trial paper. Supporting evidence for a related blend is not the same as evidence for this one.
Colostrum is often marketed for its IGF-1 content, but the evidence is mixed at best, and the doses studied are enormous compared with a capsule. A 2019 study in the European Journal of Nutrition gave healthy adults 20 grams a day for 4 weeks and 20 grams a day for 12 weeks and found no significant change in circulating IGF-1. An earlier two-week study in athletes using 20 grams a day did report a rise, though an absorption experiment in the same paper found ingested IGF-1 was fragmented and gave no support for it being absorbed intact. A daily serving of four capsules physically cannot contain anything close to 20 grams of colostrum alongside the rest of the formula.
This is a glandular ingredient, meaning it is derived from animal pituitary tissue. Its role in the formula rests on the manufacturer’s rationale rather than on independent human evidence we could locate. Because it is animal-derived, it is also something some people will want to avoid for personal or dietary reasons.
Marketed as a source of glucosamine, collagen, and growth factors. In our research we did not find independent human trial evidence supporting it as a growth-hormone-related ingredient, and like colostrum, any IGF-1 it contains would face the same digestion problem.
Included in the tablet formula tested in the trial, though it is usually added for libido-related claims rather than for IGF-1. A 2025 systematic review found no robust evidence that Tribulus raises testosterone and only low-quality evidence for erectile function, so it should be considered a supporting extra rather than a proven active.
Independent testers at Innerbody note that alpha-GPC has been shown to increase growth hormone secretion at around 1,000 mg, and that the L-dopa in Mucuna pruriens appears able to influence growth hormone at around 500 mg. The same review points out that the manufacturer does not disclose the doses in the oral spray, so there is no way to tell whether the spray contains anything near those amounts.
The Spray’s Doses Aren’t Disclosed
Because the trial tested tablets and spray together, the spray is a meaningful part of what was studied. Its ingredient doses are not published, which limits how much anyone can verify about the formula. The same Innerbody review also noted that many stand-alone amino acid supplements offer more clinically relevant doses, at a lower price, than this product.
A Website Confusion Problem
We found many websites presenting themselves as GenF20 Plus’s home, with inconsistent claims. Guarantee terms vary between them (60 days on some, 67 days on the manufacturer’s own Leading Edge Health page), and at least one GenF20-branded site claims the product is “FDA approved.” That is not true of any dietary supplement, since the FDA does not approve supplements before they are sold. Treat any page making that claim, however official it looks, with suspicion, and check terms on the manufacturer’s own site before buying.
Guarantee & Pricing
The manufacturer, Leading Edge Health, states a 67-day money-back guarantee: send back the empty bottles within 67 days for a full refund. That is a reasonable window and a real point in the product’s favor, given the trial results above. Independent testers reported that customer support responded quickly, and that the product arrived within about four days.
Pricing is on the high side. Innerbody’s independent review described it as high among growth hormone supplements, and significantly higher than many stand-alone amino acid products. Since the trial tested the tablets and spray together, you should assume you’ll need both to match the tested regimen, which raises the real monthly cost. Confirm current pricing on the official site, since offers change.
Safety and Who Should Not Take This
- Anyone with a milk allergy (the formula contains colostrum, and people with milk allergies were excluded from the trial)
- Anyone with a history of cancer, especially estrogen-sensitive cancers: IGF-1 is studied in relation to cancer risk, and the trial excluded people with those conditions
- Anyone with uncontrolled diabetes, high blood pressure, thyroid disease, significant cardiovascular disease, or liver or kidney impairment, all of whom were excluded from the trial, so its safety results don’t cover them
- Pregnant or breastfeeding women, and anyone under 18
In the trial itself, there were 12 adverse events (seven in the GenF20 Plus group and five in placebo), mostly mild digestive complaints like hyperacidity, with no serious events. That is reassuring for the healthy adults studied over 12 weeks; it says less about long-term use. This isn’t medical advice, so talk to a healthcare provider before starting any supplement, especially if you take medication or have an existing condition.
Pros & Cons
Pros
- A registered, placebo-controlled trial on the finished product exists, which most competitors lack
- The authors reported their results candidly, including the disappointing ones
- 67-day money-back guarantee from the manufacturer
- Well tolerated in the trial, with no serious adverse events
Cons
- The trial’s primary result was not statistically significant
- The headline 28% figure is a post hoc, adjusted subgroup result
- No significant difference from placebo on any clinical outcome
- Spray doses aren’t disclosed, and the tested regimen required both tablets and spray
- Pricing is high, and many look-alike websites make terms confusing
Who It’s For
GenF20 Plus makes sense, if at all, for an adult over 40 who understands what the trial did and didn’t show, is comfortable with a modest and uncertain effect, and wants to use the guarantee to test it personally rather than trust the marketing. If you’re expecting visible changes in body composition, memory, or energy on the strength of the published study, the study doesn’t support that expectation. The honest summary is that it’s a plausible idea with a real but weak evidence base, sold with stronger claims than the research supports.
FAQ
Does GenF20 Plus really raise IGF-1 by 28%?
Only in one specific, adjusted analysis of adults 40 and older that was run after the results were known. The trial’s main comparison, across all participants, showed no significant difference from placebo.
Is GenF20 Plus clinically proven?
It has been clinically studied. The published trial did not show significant differences from placebo on its main outcome or on any of the body composition, memory, libido, energy, or sleep measures it tracked.
Do I need the spray as well as the tablets?
The trial tested the two together, so tablets alone are not the tested regimen. The spray’s doses are not published, so it’s hard to say how much it contributes.
Can oral supplements really raise growth hormone like injections do?
Injected HGH is a prescription hormone given at defined doses. Oral supplements try to nudge your body’s own production, which is a much weaker and less predictable approach. The famous studies of injected HGH don’t tell you what a capsule does.
Is it safe?
In the 12-week trial there were no serious adverse events and the most common complaints were mild digestive issues. People with several common conditions (including uncontrolled diabetes, thyroid disease, and significant heart disease) were excluded from that trial, and long-term safety data is limited.
Do I need a prescription?
No, it’s an over-the-counter dietary supplement, not a prescription medication or a substitute for one.
Ready to check current pricing?
Visit the Official SiteLast reviewed September 2026 · Read our rating methodology · Clinical reference: Sonawane et al., 2015, Open Access Journal of Clinical Trials.